title: High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
abstract: Extensive researches have found that the mutation of p53 tumor suppressor gene is the most frequent event in many human cancers and associated with a poor clinical outcome in lung cancer patients. Because the p53 molecular mutation involved in tumorigenesis of patients with lung cancer in Taiwan remains poorly defined, the aim of this study was to assess the p53 mutation spectrum and possible etiological factors of Taiwan's patients with Non-Small Cell Lung Cancer (NSCLC). Cancer specimens were obtained surgically from 61 patients with pathologically proven NSCLC. Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) and direct sequencing were used to study p53 mutations in exon 4-8. We also performed immunohistochemistry (IHC) to detect p53 protein expression. Our results provided that 34 mutations of p53 gene were found in 27 cases with a mutation rate of 44% (27/61). There were six cases having more than two p53 mutations. Among the 34 mutations, 19 were point mutations (56%, 19/34) consisted of a majority of missense mutations including transversion (13/19, 68%) and transitions (6/19, 32%) with four cases (4/6, 67%) occurring in the CpG sequence. One of the most important finding in our study was the high frequency of frameshift (44%, 15/34) which included 11 insertions and 4 deletions of p53 in NSCLC in Taiwan. Surprisingly, our results disclosed distinct novel mutations at codon 181, 185, 208 (Exon 5-6) of p53. Especially, 4 cases with mutation at codon181 and codon 185 seemed to have more advanced clinical outcome with survival time less than 6 months. In addition, there were two recurring mutations at codon 168 and three at condon193. The different mutation spectrum in our series, including a high frequency of frameshift mutations and distinctly novel hot spots suggested the heterogenous entity of exogenous mutagens in NSCLC in Taiwan.
authors.affiliation: MedicoGenomic Research Center, Kaohsiung Medical University, 100 Shih-Chuan 1st Road, Kaohsiung 807, Taiwan, ROC.
authors.forename: Mei-Yin
authors.initials: MY
authors.lastname: Chang
authors.forename: Inn-Wen
authors.initials: IW
authors.lastname: Chong
authors.forename: Fang-Ming
authors.initials: FM
authors.lastname: Chen
authors.forename: Jaw-Yuan
authors.initials: JY
authors.lastname: Wang
authors.forename: Tian-Lu
authors.initials: TL
authors.lastname: Cheng
authors.forename: Yu-Jen
authors.initials: YJ
authors.lastname: Cheng
authors.forename: Chau Chyun
authors.initials: CC
authors.lastname: Sheu
authors.forename: Sung-Yu
authors.initials: SY
authors.lastname: Hung
authors.forename: Ming-Chen
authors.initials: MC
authors.lastname: Yang
authors.forename: Shiu-Ru
authors.initials: SR
authors.lastname: Lin
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000209:etiology / Q000235:genetics*; D002471:Cell Transformation, Neoplastic; D004252:DNA Mutational Analysis; D005260:Female; D016368:Frameshift Mutation; D016158:Genes, p53; D006801:Humans; D008175:Lung Neoplasms / Q000209:etiology / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D018807:Polymorphism, Single-Stranded Conformational; D011379:Prognosis; D013624:Taiwan